This text is a result of machine translation.
Excess PV silicon? Industry: the development of large-size silicon wafers exceeds expectations, and the supply is still tight
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Huzhou: there is no time limit for non registered residence residents to continuously pay social security when purchasing houses in central cities
The price of new n-type monocrystalline silicon wafer of Zhonghuan Co., Ltd. is 6% higher than that of p-type silicon wafer with the same thickness
Taier shares: the contract dispute case against Cao Linbin was accepted by the court
Luyang energy conservation: the controlling shareholder plans to suspend the trading of shares in major events
Zhongji InnoLight Prices Hong Kong Listing at HK$980, Raising HK$53.41 Billion
Zhongji InnoLight Co., Ltd.(中际旭创股份有限公司), a leading Chinese supplier of optical transceivers used in cloud and artificial-intelligence infrastructure, has priced its Hong Kong H-share offering at HK$980 per share, giving the base deal gross proceeds of HK$53.41 billion (US$6.81 billion).
Jul 28, 2026 11:09 AM
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
The annual report is superimposed on the first quarterly report, and the highlights of listed companies are frequent
Central Co., Ltd. comprehensively raised the price of p-type monocrystalline silicon wafer
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
The Commerce Department said the shortage of chips would continue for at least six months
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 28, 2026 03:24 PM
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM